Pharmacist

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort

Retrieved on: 
星期一, 三月 4, 2024

OptimizeRx’s Dynamic Audience Activation Platform (DAAP), is helping to connect healthcare providers with Walmart’s growing network of nearly 90 SPOCs across 13 states.

Key Points: 
  • OptimizeRx’s Dynamic Audience Activation Platform (DAAP), is helping to connect healthcare providers with Walmart’s growing network of nearly 90 SPOCs across 13 states.
  • This collaboration aims to help HCPs identify a new solution for patients facing barriers to care, particularly those living with HIV and autoimmune conditions.
  • “Collaborating with OptimizeRx has been instrumental in facilitating and coordinating access to a network of crucial healthcare providers - those treating patients with complex conditions.
  • “Collaborating with Walmart on this impactful initiative is a strategic milestone for OptimizeRx, reinforcing our commitment to improving patient access to vital resources,” said Steve Silvestro, President of OptimizeRx.

Time to invest in team-based care and the training for health professionals who provide it: Team Primary Care Summit

Retrieved on: 
星期三, 二月 28, 2024

OTTAWA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Health care professionals from across Canada are urging governments to invest in interprofessional, comprehensive team-based care and provide training to those who deliver it.

Key Points: 
  • Team Primary Care leaders discuss the importance of training for successful primary care reform at their 2024 Summit in Ottawa, ON
    OTTAWA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Health care professionals from across Canada are urging governments to invest in interprofessional, comprehensive team-based care and provide training to those who deliver it.
  • That is the message from the Team Primary Care Summit, which took place February 22 to 23, 2024, in Ottawa, Ontario.
  • The summit saw more than 300 health professionals, educators, and organization leaders from across the country gathered to discuss the urgent need for comprehensive team-based primary care.
  • In team-based care, patients are connected to a group of health professionals and can access high-quality care when and where they need it.

Local Pharmacies on the Brink, New Survey Reveals

Retrieved on: 
星期二, 二月 27, 2024

The rule is intended to give pharmacies and patients more transparency on drug pricing.

Key Points: 
  • The rule is intended to give pharmacies and patients more transparency on drug pricing.
  • According to the new NCPA survey, 32 percent of all respondents say they are considering closing their doors in 2024 because of the cash crunch.
  • Increased vertical and horizontal consolidation of PBMs and health plans has caused severe inequities to pharmacies and Medicare Part D beneficiaries alike.
  • Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers.

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

Retrieved on: 
星期二, 二月 27, 2024

The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, and Poland.

Key Points: 
  • The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, and Poland.
  • The academic networks participating in each country are Geicam (Spain), Unicancer (France), GBG (Germany), GIM (Italy), and a network of Polish sites.
  • We look forward to working very closely with our European colleagues and will start by training site staff, pharmacists, and nurses.
  • We hope to open sites as quickly as possible, while applying to open additional sites in the approved countries and potentially adding additional countries in Europe."

Hydreight Partners with Ola Digital Health, an Independent, National Pharmacy Network to Provide Health and Wellness Services in Store

Retrieved on: 
星期一, 二月 26, 2024

VANCOUVER, British Columbia and LAS VEGAS, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:NURS)(OTCQB:HYDTF)(FSE:S06) a mobile clinical network and medical platform which enables flexible, at-home medical services across 50 states in the United States, is very pleased to announce that it has entered into a partnership with Ola Digital Health (“Ola”) an innovative healthcare platform with a national pharmacy network in the United States, to provide health and wellness services inside its network of brick and mortar locations.

Key Points: 
  • Ola Digital Health is an innovative healthcare company with a network of 300 independent retail pharmacies in the United States.
  • Hydreight will be the health and wellness service provider in seven pharmacy locations as part of Phase I rollout, starting in February 2024.
  • Based on the success of Phase I, Ola will leverage its 300-pharmacy network to utilize these services.
  • Hydreight will leverage its proprietary healthtech platform, doctor and nurse network, and pharmacy distribution to provide its services to patients within the brick-and-mortar locations.

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment

Retrieved on: 
星期五, 二月 23, 2024

“These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.

Key Points: 
  • “These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.
  • These analyses present the overall attack rate progression and attack rate progression stratified by severity (i.e., number of attacks at baseline), prior prophylaxis and C1-INH level and function.
  • These findings further demonstrate that ORLADEYO can help maintain disease control in patients with lower baseline attack rates and further reduce attack rates in patients with more active disease.
  • Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes; Poster #012; Friday, February 23, 3:15-4:15 p.m.

Pharmacy Benefit Management Institute® (PBMI) announces open registration for PBMI MAP: Managing Access and Patient Care

Retrieved on: 
星期五, 二月 23, 2024

CRANBURY, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- The Pharmacy Benefit Management Institute (PBMI), the nation’s leading provider of research and education on drug cost management, is pleased to announce open registration for the PBMI MAP: Managing Access and Patient Care virtual forum.

Key Points: 
  • CRANBURY, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- The Pharmacy Benefit Management Institute (PBMI), the nation’s leading provider of research and education on drug cost management, is pleased to announce open registration for the PBMI MAP: Managing Access and Patient Care virtual forum.
  • The forum will be held on March 8, 2024, where participants can join from the comfort of their homes.
  • The event is open to pharmacy benefit managers, self-insured employers, employer groups, commercial health plans, specialty pharmacy providers, third-party administrators, PBM service providers and pharmacy benefit consultants.
  • The event will include the following sessions:
    Current Landscape of Oncology Management, Access, and Patient Outcomes
    The event will feature the following esteemed faculty: Cheryl Allen B.S.

Proton Capital Enters Into Agreement to Purchase PharmaChoice Canada Branded Pharmacy In Saskatoon For Proposed Qualifying Transaction

Retrieved on: 
星期四, 二月 22, 2024

The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.

Key Points: 
  • The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.
  • The Qualifying Transaction will not constitute a Non-Arm’s Length Qualifying Transaction (as such term is ‎defined in the policies of the TSXV).
  • The parties to the Qualifying Transaction are at arm’s length and therefore the approval of the shareholders of ‎Proton in respect of the Qualifying Transaction will not be required.
  • The Prospectus will contain important detailed information about the Corporation, the Qualifying ‎Transaction and the proposed Offering.

Stuart Piltch Appointed President of Risk Strategies Consulting

Retrieved on: 
星期四, 二月 22, 2024

BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management firm, today announced that it has appointed Stuart Piltch as President of its Risk Strategies Consulting business segment.

Key Points: 
  • BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management firm, today announced that it has appointed Stuart Piltch as President of its Risk Strategies Consulting business segment.
  • A 35-year consulting industry veteran, Piltch joined Risk Strategies through the 2021 acquisition of Cambridge Advisory Group, a pharmacy, actuarial and benefits consulting firm based in Pennsylvania.
  • “Today’s highly complex employee benefits world requires an innovative approach to harnessing and understanding data,” said John Greenbaum, Executive Vice President, Risk Strategies Consulting.
  • “Risk Strategies understanding of the power of specialization and expertise is unique within its market segments,” said Piltch.

AssureCare Revolutionizes Pharmacist Credentialing with Groundbreaking Solution

Retrieved on: 
星期四, 二月 22, 2024

Health systems and clinics benefit from a credentialing department, AssureCare now enables community pharmacists to have the same capability through its AssureRx platform.

Key Points: 
  • Health systems and clinics benefit from a credentialing department, AssureCare now enables community pharmacists to have the same capability through its AssureRx platform.
  • AssureCare introduces a new AssureRx solution designed to navigate the intricacies of pharmacist credentialing with unparalleled expertise.
  • The combined impact of AssureRx’s innovative credentialing platform, pharmacy professionals, and credentialing specialists will help pharmacists prepare their pharmacy for the future.
  • “We understand the challenges pharmacist providers face in navigating the credentialing landscape,” states Tara Pfund, PharmD at AssureCare, “and we want to help relieve that burden and advocate for change.” AssureRx is committed to revolutionizing the pharmacist credentialing process, providing a one-stop solution for professionals seeking integration into medical plans.